| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |